KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 106 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,890,000 | -28.6% | 814,250 | -26.8% | 3.56% | +3.6% |
| Q1 2022 | $11,058,000 | -8.3% | 1,112,500 | +8.5% | 3.43% | +34.2% |
| Q4 2021 | $12,064,000 | -19.1% | 1,025,000 | -21.8% | 2.56% | -8.2% |
| Q3 2021 | $14,921,000 | -7.3% | 1,310,000 | +13.4% | 2.79% | +4.3% |
| Q2 2021 | $16,092,000 | +170.9% | 1,155,200 | +260.0% | 2.67% | +206.5% |
| Q1 2021 | $5,940,000 | +50.0% | 320,926 | +43.2% | 0.87% | +68.7% |
| Q4 2020 | $3,960,000 | -54.9% | 224,100 | -33.7% | 0.52% | -69.9% |
| Q3 2020 | $8,778,000 | 0.0% | 338,000 | -1.9% | 1.72% | -3.2% |
| Q2 2020 | $8,778,000 | – | 344,500 | – | 1.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |